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Staphylococcus aureus is a major nosocomial pathogen that
causes a range of infections. Methicillin-resistant S. aureus
(MRSA) was first detected in the early 1960s, shortly after the
introduction of methicillin, and it has become associated
with hospital outbreaks globally. In recent years, infection
caused by community-acquired MRSA (CA-MRSA) as an emer-
ging infectious disease has been reported with increasing
frequency around the world.1 In Shanghai, China, the inci-
dence of MRSA among S. aureus strains increased from 24% to
64% during a 20-year period from 1985 to 2004.2 In Asia, CA-
MRSA strains have been identified in Japan, Singapore, Hong
Kong, and Taiwan, however no report is available from main-
land China, where the incidence of MRSA is high. Panton—
Valentine leukocidin (PVL) is a cytotoxin of S. aureus that has
been supposed to be associated with primary skin infections
and community-acquired severe necrotic pneumonia.3 The
aim of the present study was to screen for MRSA strains
harboring the pvl gene isolated in Shanghai.
A total of 114 MRSA isolates from Huashan Hospital,
Shanghai, China during 1999 and 2005 were investigated in
the study. Strains were collected from nine outpatients and
from 105 inpatients. The isolates were recovered from
wounds (79.8%), pus (10.5%), pleural liquid (5.3%), and blood
(4.4%). The identities of the S. aureus isolates were con-
firmed by colony morphology, Gram-staining, and the coagu-
lase test. Methicillin resistance was screened by oxacillin disk
(1 mg).4 The presence ofmecA and nuc genes was verified by a
duplex PCR.
The minimum inhibitory concentrations (MICs) of the
following eight antimicrobial agents were determined by
broth microdilution method (dry-form commercial MIC
panels, Sensititre, TREK Diagnostics, UK): dalbavancin, van-
comycin, teicoplanin, linezolid, quinupristin—dalfopristin,
oxacillin, ampicillin, and clindamycin. The results were
interpreted according to Clinical and Laboratory Standards
Institute (CLSI) criteria, except for dalbavancin, for which
the susceptibility and resistance breakpoints have not yet
been established.5
The detection of the pvl gene was carried out by a PCR
assay as previously described.6 pvl gene-positive strains were
further investigated by molecular typing. The SCCmec typing
was carried out by a PCR SCCmec typing scheme, i.e., mec
complex and ccr complex typing according to Zhang et al.7Table 1 Susceptibilities of 114 MRSA strains to eight antimicrob
Antibiotics MIC (mg/L)
MIC range MIC50 MIC9
Dalbavancin 0.06—0.25 0.125 0.12
Vancomycin 1—2 2 2
Teicoplanin 0.5—8 1 2
Linezolid 1—2 2 2
Quinupristin—dalfopristin 0.25—2 0.5 1
Oxacillin >16 >16 >16
Ampicillin 16—>16 >16 >16
Clindamycin >16 >16 >16and PCR-restriction fragment length polymorphism (RFLP)
method by Yang et al.8 The spa (staphylococcal protein
A gene) typing was performed as previously described.9
DNA sequencing was conducted on a 310 Genetic Analyzer
(Applied Biosystems). spa Types were analyzed with
the Ridom StaphType software (Ridom GmbH, Wu¨rzburg,
Germany).
The susceptibilities of the 114 MRSA isolates to the eight
antimicrobial agents are listed in Table 1. All the strains were
susceptible to vancomycin, linezolid, quinupristin—dalfopris-
tin, and dalbavancin, while five of them were intermediately
susceptible to teicoplanin with MICs at 8 mg/L. The strains
were resistant to oxacillin, ampicillin, and clindamycin.
Among the 114 MRSA strains, one was identified to be pvl
gene positive, while all the others were negative. The pvl-
positive strain was confirmed to carry SCCmec IV by both
methods employed, and belonged to t318 in spa typing with a
repeat succession 15-12-16-16-02-16-02-25-17-24.
S. aureuswith spa type t318 has been found in Cape Verde,
the UK, Denmark, Norway, Belgium, Germany, and France
(http://spa.ridom.de/frequencies.shtml). Further investi-
gation is necessary for the clarification of the dissemination
and frequency of this clone both locally and nationally.
In the present study, the pvl-positive MRSA isolate was
detected from a patient with a breast abscess. The case was a
typical soft tissue infection that occurred in a previously
healthy, young woman with no known risk factors for MRSA
acquisition. According to the available case history, the
infection was acquired outside the hospital setting, which
was also supported by the genotypic findings for this strain.
To our knowledge, this is the first report frommainland China
of an infection caused by pvl-positive MRSA. Clinically, pvl-
positive S. aureus shows a predilection for causing necrotic
lesions of the skin and respiratory mucosa. In addition, the
mortality associated with pvl-positive S. aureus has been
shown to be significantly higher than that caused by pvl-
negative S. aureus (37% vs. 6% at 48 hours).10
MRSA isolates with reduced susceptibility to teicoplanin
were also observed in the study, which has not yet been
reported in Shanghai. Although the five isolates were inter-
mediately susceptible to teicoplanin, this is a warning that S.
aureus strains with full resistance might emerge in the
future if this kind of antibiotic is widely used without control.
Strict infection control practices, routine screening for resis-
tance, and controlled use of antibacterial agents, especially
glycopeptides, are critical steps in preventing the further
development of resistance among staphylococci.ial agents from Shanghai, China
Percentage by category
0 Susceptible % Intermediate % Resistant %
5 — — —
100 0.0 0.0
95.6 4.4 0.0
100 0.0 0.0
100 0.0 0.0
0.0 0.0 100
0.0 0.0 100
0.0 0.0 100
Letters to the Editor 483In conclusion, this is the first reported case of an infection
caused by MRSA carrying the Panton—Valentine leukocidin
(PVL) gene in Shanghai, China. The emergence of such strains
in Shanghai, a densely populated city with a high incidence of
MRSA, indicates the necessity of epidemiological surveillance
of these clinically important strains.
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doi:10.1016/j.ijid.2006.06.002Nocardia veterana bloodstream infection in a
patient with cancer and a summary of reported
cases
Nocardia species are aerobic nocardioform actinomycetes
associated most commonly with pulmonary and central ner-
vous system infections in patients with cellular immune
defects.1—3 Nocardia bloodstream infections, however, are
seldom seen even in severely immunosuppressed patients
with an underlying malignancy.4,5 Most systemic infections
are due to Nocardia asteroides complex including N. aster-
oides sensu stricto, Nocardia farcinica, and Nocardia nova. In
recent years, molecular methods that rely on 16S rRNA gene
sequencing have resulted in the reclassification of some
actinomycetes and in the identification of previously
unknown species.6—8 Nocardia veterana is among these newly
identified species.9 N. veterana has been reported to cause
pneumonia, ascites, and mycetoma; however, bloodstream
infection with N. veterana has not been described.9—13We present herein the case of a cancer patient with N.
veterana bacteremia complicating a pulmonary infection.
We also review the published cases of N. veterana infections
in humans.
A 58-year-old man with chronic lymphocytic leukemia and
non-small cell lung carcinoma of the right lung presented
with a five-day history of fever, dyspnea, right lower chest
pain, and a productive cough that exacerbated the pain. The
patient had recently received fludarabine, cyclophospha-
mide, and rituximab for relapsed leukemia; treatment for
the lung cancer had not been started. Three months prior
to this presentation, the patient was given prednisone
(20 mg/day) for refractory autoimmune hemolytic anemia
and thrombocytopenia. In the month preceding this presen-
tation, the patient had been hospitalized for possible fungal
pneumonia.
On chest auscultation at presentation, decreased
breath sounds were noted in the upper right lung and were
accompanied by coarse sounds throughout the lung; a
grade 2/6 mid-systolic heart murmur was also audible.
